131 related articles for article (PubMed ID: 11447833)
1. Receptor-G-protein signalling in Alzheimer's disease.
Cowburn RF; O'Neill C; Bonkale WL; Ohm TG; Fastbom J
Biochem Soc Symp; 2001; (67):163-75. PubMed ID: 11447833
[TBL] [Abstract][Full Text] [Related]
2. Quantitative autoradiography of [3H]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
García-Jiménez A; Cowburn RF; Ohm TG; Bogdanovic N; Winblad B; Fastbom J
Brain Res; 1999 Dec; 850(1-2):104-17. PubMed ID: 10629754
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease.
Greenwood AF; Powers RE; Jope RS
Neuroscience; 1995 Nov; 69(1):125-38. PubMed ID: 8637611
[TBL] [Abstract][Full Text] [Related]
4. Adenylyl cyclase activity in Alzheimer's disease brain: stimulatory and inhibitory signal transduction pathways are differently affected.
Schnecko A; Witte K; Bohl J; Ohm T; Lemmer B
Brain Res; 1994 May; 644(2):291-6. PubMed ID: 7914148
[TBL] [Abstract][Full Text] [Related]
5. Loss of stimulatory effect of guanosine triphosphate on [(35)S]GTPgammaS binding correlates with Alzheimer's disease neurofibrillary pathology in entorhinal cortex and CA1 hippocampal subfield.
García-Jiménez A; Cowburn RF; Ohm TG; Lasn H; Winblad B; Bogdanovic N; Fastbom J
J Neurosci Res; 2002 Feb; 67(3):388-98. PubMed ID: 11813244
[TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain.
Mahlapuu R; Viht K; Balaspiri L; Bogdanovic N; Saar K; Soomets U; Land T; Zilmer M; Karelson E; Langel U
Brain Res Mol Brain Res; 2003 Sep; 117(1):73-82. PubMed ID: 14499483
[TBL] [Abstract][Full Text] [Related]
7. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain.
O'Neill C; Wiehager B; Fowler CJ; Ravid R; Winblad B; Cowburn RF
Brain Res; 1994 Feb; 636(2):193-201. PubMed ID: 8012802
[TBL] [Abstract][Full Text] [Related]
8. Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells.
De Sarno P; Bijur GN; Lu R; Davis RE; Jope RS
Neurobiol Aging; 2000; 21(1):31-8. PubMed ID: 10794846
[TBL] [Abstract][Full Text] [Related]
9. Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.
Liebmann C; Graness A; Ludwig B; Adomeit A; Boehmer A; Boehmer FD; Nürnberg B; Wetzker R
Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):109-18. PubMed ID: 8546671
[TBL] [Abstract][Full Text] [Related]
10. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
[TBL] [Abstract][Full Text] [Related]
11. Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology.
Kurumatani T; Fastbom J; Bonkale WL; Bogdanovic N; Winblad B; Ohm TG; Cowburn RF
Brain Res; 1998 Jun; 796(1-2):209-21. PubMed ID: 9689471
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins.
Pavía J; de Ceballos ML; Sanchez de la Cuesta F
Fundam Clin Pharmacol; 1998; 12(5):473-81. PubMed ID: 9794144
[TBL] [Abstract][Full Text] [Related]
13. Neurotransmitters, signal transduction and second-messengers in Alzheimer's disease.
Cowburn RF; Fowler CJ; O'Neill C
Acta Neurol Scand Suppl; 1996; 165():25-32. PubMed ID: 8740986
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
15. Disturbances in signal transduction mechanisms in Alzheimer's disease.
Fowler CJ; Cowburn RF; Garlind A; Winblad B; O'Neill C
Mol Cell Biochem; 1995; 149-150():287-92. PubMed ID: 8569742
[TBL] [Abstract][Full Text] [Related]
16. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
17. Impaired phosphoinositide hydrolysis in Alzheimer's disease brain.
Jope RS; Song L; Li X; Powers R
Neurobiol Aging; 1994; 15(2):221-6. PubMed ID: 7838295
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease.
Pei JJ; Braak H; An WL; Winblad B; Cowburn RF; Iqbal K; Grundke-Iqbal I
Brain Res Mol Brain Res; 2002 Dec; 109(1-2):45-55. PubMed ID: 12531514
[TBL] [Abstract][Full Text] [Related]
19. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction via the B cell antigen receptor: involvement of a G protein and regulation of signaling.
DeFranco AL; Gold MR
Adv Exp Med Biol; 1989; 254():101-12. PubMed ID: 2554695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
